Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemias”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07206472
What this trial is testing

Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

Who this might be right for
Primary HypercholesterolaemiaMixed Dyslipidemia
Daiichi Sankyo 2,120
Large-scale testing (Phase 3)Study completedNCT00092573
What this trial is testing

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 576
Large-scale testing (Phase 3)Study completedNCT00465088
What this trial is testing

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Abbott 199
Large-scale testing (Phase 3)UnknownNCT01956201
What this trial is testing

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

Who this might be right for
Mixed Hyperlipidemia
Chong Kun Dang Pharmaceutical 476
Not applicableStudy completedNCT07409636
What this trial is testing

Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 11,991
Large-scale testing (Phase 3)Study completedNCT00300482
What this trial is testing

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Who this might be right for
DyslipidemiaCoronary Heart DiseaseMixed Dyslipidemia
Abbott 1,445
Large-scale testing (Phase 3)Study completedNCT00376584
What this trial is testing

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Who this might be right for
HypercholesteremiaHyperlipidemia
Merck Sharp & Dohme LLC 825
Early research (Phase 1)Not Yet RecruitingNCT06976489
What this trial is testing

The Food Effect on PK Characteristics and Safety Profiles of PA-111

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07444086
What this trial is testing

QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 510
Not applicableActive Not RecruitingNCT05399992
What this trial is testing

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 847
Large-scale testing (Phase 3)Study completedNCT01968954
What this trial is testing

Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Who this might be right for
Hyperlipidemia
Pfizer 711
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750341
What this trial is testing

Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 156
Post-approval studies (Phase 4)Study completedNCT00678743
What this trial is testing

An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Who this might be right for
Dyslipidemias
Provident Clinical Research 17
Large-scale testing (Phase 3)Study completedNCT02739984
What this trial is testing

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed DyslipidemiaType 2 Diabetes
Amgen 424
Not applicableLooking for participantsNCT06770543
What this trial is testing

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 1,500
Large-scale testing (Phase 3)Looking for participantsNCT05400317
What this trial is testing

Evaluate the Efficacy and Safety of AD-218

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 520
Post-approval studies (Phase 4)WithdrawnNCT02069106
What this trial is testing

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Who this might be right for
Mixed Hyperlipoproteinemia
Nordic Pharma, USA
Large-scale testing (Phase 3)Ended earlyNCT03433755
What this trial is testing

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 259
Large-scale testing (Phase 3)Study completedNCT00479882
What this trial is testing

MK-0524B Lipid Study (MK-0524B-063)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 2,414
Not applicableStudy completedNCT05546398
What this trial is testing

SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI®

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation